SANBIO COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 411 JPY | -1.20% |
|
-3.07% | -41.45% |
| Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
| Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Chart calendar SanBio Company Limited
40bd0bd355e7cf3e01a80b30cb5990f._mAiWs9OwfOZqEULpL--rDzrunxGFLR5RZZxri6kAfM.qRpwMfY_s8f15zZa5ovo2Q2C8gUzX4YQc_wG12rGc5S_IW4OiCKlrMuRHA~9a74dbbb3835b6ff61924425d2fd6f64
Upcoming events on SanBio Company Limited
Past events on SanBio Company Limited
| 2024-03-17 | Q4 2023 Earnings Release |
| 2023-12-13 | Q3 2023 Earnings Release |
| 2023-09-13 | Q2 2023 Earnings Release |
| 2023-06-13 | Q1 2023 Earnings Release |
| 2023-04-25 | Annual General Meeting |
| 2023-03-15 | Q4 2022 Earnings Release |
| 2022-12-14 | Q3 2023 Earnings Release |
| 2022-06-13 | Q1 2022 Earnings Release |
| 2022-04-05 12:15 pm | American Academy of Neurology Meeting |
| 2022-03-10 | FY 2021 Earnings Call |
| 2022-03-10 | FY 2021 Earnings Release |
| 2021-12-14 | Q3 2021 Earnings Release |
| 2021-09-13 | Interim 2021 Earnings Release |
| 2021-06-13 | Q1 2021 Earnings Release |
| 2021-03-16 | FY 2020 Earnings Release |
| 2020-12-14 | Q3 2020 Earnings Release |
| 2020-09-13 | Interim 2020 Earnings Release |
| 2020-06-11 | Q1 2020 Earnings Release |
| 2020-04-27 | Annual General Meeting |
| 2020-03-18 12:00 am | FY 2019 Earnings Call |
Annual results
| Fiscal Period | January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 742 741 0.07% | 447 444 0.68% | 0,00 403 - | 0,00 0,00 - | 0,00 219 - | 0,00 0,00 - |
|
EBITDA Million JPY | Released Forecast Spread | -3 697 -3 628 -1.91% | -5 446 -4 831 -12.74% | -5 727 -5 911 3.11% | -6 488 -6 332 -2.47% | -7 875 -7 851 -0.3% | -4 525 -4 480 -1.02% |
|
EBIT Million JPY | Released Forecast Spread | -3 734 -3 864 3.36% | -5 486 -5 083 -7.94% | -5 802 -6 023 3.67% | -6 620 -6 589 -0.47% | -7 899 -7 444 -6.12% | -4 540 -5 176 12.3% |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -2 919 -3 114 6.24% | -5 157 -4 605 -11.98% | -3 211 -6 669 51.84% | -4 560 -4 515 -1% | -4 697 -4 046 -16.09% | -2 542 -3 731 31.87% |
|
Net income Million JPY | Released Forecast Spread | -2 921 -3 080 5.18% | -5 158 -4 607 -11.96% | -3 386 -6 133 44.8% | -4 677 -4 617 -1.3% | -5 559 -5 076 -9.52% | -2 644 -4 079 35.16% |
|
EPS JPY | Released Forecast Spread | -60,2 -63,3 4.88% | -101 -90,7 -11.27% | -65,4 -119 44.92% | -90,3 -89,2 -1.31% | -96,0 -89,1 -7.76% | -40,5 -63,1 35.89% |
| Announcement Date | 15/03/19 | 16/03/20 | 17/03/21 | 11/03/22 | 16/03/23 | 18/03/24 |
Quarterly results
| Fiscal Period | January | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 427 | 19,5 22,0 -11.55% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 875 - | 0,00 174 - | 0,00 349 - | 0,00 523 - | 0,00 523 - | 698 | |||
|
EBIT Million JPY | Released Forecast Spread | -2 385 | -3 101 -2 715 -14.21% | -2 570 | -3 232 -3 129 -3.28% | -3 052 | -1 687 | -1 844 -1 400 -31.71% | -2 778 -1 317 -110.93% | -4 622 -3 161 -46.22% | -1 783 -1 427 -24.95% | -1 494 -530 -181.9% | -1 461 -1 746 16.32% | -1 623 -1 104 -47.02% | -3 085 -2 850 -8.24% | -640 -1 092 41.36% | -814 -703 -15.75% |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -2 047 | -3 109 -2 553 -21.79% | -3 205 | -6,00 -2 593 99.77% | -2 127 | -886 | 869 | -774 | 1 211 | -866 | -1 858 | 116 | ||||
|
Net income Million JPY | Released Forecast Spread | -2 048 | -3 109 -2 551 -21.87% | -3 207 | -179 -2 593 93.1% | -2 134 | -981 | -315 | -2 154 | 396 | -626 | -1 787 | -96,0 | ||||
|
EPS JPY | Released Forecast Spread | -40,6 | -61,9 | -41,2 | -19,0 | -5,98 | -39,3 | 8,14 | -9,68 | -27,6 | -1,40 | ||||||
| Announcement Date | 13/09/19 | 16/03/20 | 14/09/20 | 17/03/21 | 14/09/21 | 15/12/21 | 14/06/22 | 14/09/22 | 14/09/22 | 15/12/22 | 16/03/23 | 14/06/23 | 14/09/23 | 14/09/23 | 14/12/23 | 18/03/24 |
More events
Past sector events for SanBio Company Limited
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ACELYRIN, INC.: Q4 2023 Earnings Release |
| 2024-03-28 04:02 pm | IMMUNOME, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4592 Stock
- Calendar SanBio Company Limited
